NeuroSense Therapeutics (NRSN) Assets (2020 - 2025)
NeuroSense Therapeutics (NRSN) posted Assets of $1.0 million for Q4 2025, down 38.95% sequentially from $1.7 million in Q2 2025, and down 77.53% YoY from $4.6 million in Q4 2024.
NeuroSense Therapeutics (NRSN) Assets (2020 - 2025) Analysis & Trends
NeuroSense Therapeutics has reported Assets for 6 years, with the latest figure at $1.0 million in Q4 2025.
- Quarterly Assets fell 77.53% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (down 77.53% YoY) and the FY2025 annual result came in at $1.0 million, down 77.53% from the prior year.
- Assets retreated to $1.0 million in Q4 2025 per NRSN's latest filing, from $1.7 million in the prior quarter.
- Over five years, Assets peaked at $14.4 million in Q1 2022 and troughed at $984000.0 in Q3 2024.
- A 5-year average of $5.8 million and a median of $5.3 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2021 and 2024: Assets jumped 1367.39% in 2021, then plunged 81.73% in 2024.
- Over 5 years, Assets stood at $11.4 million in 2021, then tumbled by 32.49% to $7.7 million in 2022, then sank by 58.73% to $3.2 million in 2023, then jumped by 43.64% to $4.6 million in 2024, then plunged by 77.53% to $1.0 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $1.0 million, $1.7 million, and $4.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | NeuroSense Therapeutics | 9.68 Mn | 9.47 Mn | - | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Dec 31, 2024 | 4.58 Mn |
| Sep 30, 2024 | 984,000.00 |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 5.39 Mn |
| Jun 30, 2023 | 7.87 Mn |
| Mar 31, 2023 | 5.34 Mn |
| Dec 31, 2022 | 7.72 Mn |
| Sep 30, 2022 | 9.23 Mn |
| Jun 30, 2022 | 11.45 Mn |
| Mar 31, 2022 | 14.36 Mn |
| Dec 31, 2021 | 11.43 Mn |
| Dec 31, 2020 | 779,000.00 |